HMOX1 and rheumatoid arthritis: Our study provides supporting evidence that galuteolin may activate HO-1 and inactivate the IKKβ/NF-κB signaling pathway, resulting in the suppression of synoviocyte proliferation and inflammation as well as the promotion of synoviocyte apoptosis in RA.